<List><item><source>MED</source><extId>30767166</extId><pmcid>PMC6439041</pmcid><annotations><annotation><prefix>e ON-TIMEÂ 3 trial (</prefix><exact>NCT03400267</exact><postfix>) aims to achieve op</postfix><tags><tag><name>NCT03400267</name><uri>http://identifiers.org/clinicaltrials/NCT03400267</uri></tag></tags><id>http://europepmc.org/abstract/MED/30767166#europepmc-a15ef62a6e90ab9c7f3c089077627541</id><type>Accession Numbers</type><section>Abstract (http://purl.org/dc/terms/abstract)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>is registered on ClinicalTrials.gov (</prefix><exact>NCT03400267</exact><postfix>). </postfix><tags><tag><name>NCT03400267</name><uri>http://identifiers.org/clinicaltrials/NCT03400267</uri></tag></tags><id>http://europepmc.org/articles/PMC6439041#europepmc-4e6144db9e1fda90a844854e3eb0003c</id><type>Accession Numbers</type><section>Methods (http://purl.org/orb/Methods)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>